Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Similar articles for PubMed (Select 24718980)

1.

A service development study of the assessment and management of fracture risk in Parkinson's disease.

Shribman S, Torsney KM, Noyce AJ, Giovannoni G, Fearnley J, Dobson R.

J Neurol. 2014 Jun;261(6):1153-9. doi: 10.1007/s00415-014-7333-8. Epub 2014 Apr 10.

2.

clinical risk factors for osteoporosis in Ireland and the UK: a comparison of FRAX and QFractureScores.

Cummins NM, Poku EK, Towler MR, O'Driscoll OM, Ralston SH.

Calcif Tissue Int. 2011 Aug;89(2):172-7. doi: 10.1007/s00223-011-9504-2. Epub 2011 Jun 7.

PMID:
21647704
4.

Does osteoporosis therapy invalidate FRAX for fracture prediction?

Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA; Manitoba Bone Density Program.

J Bone Miner Res. 2012 Jun;27(6):1243-51. doi: 10.1002/jbmr.1582.

PMID:
22392538
5.

Evaluation of the FRAX and Garvan fracture risk calculators in older women.

Bolland MJ, Siu AT, Mason BH, Horne AM, Ames RW, Grey AB, Gamble GD, Reid IR.

J Bone Miner Res. 2011 Feb;26(2):420-7. doi: 10.1002/jbmr.215.

PMID:
20721930
6.

FRAX® tool, the WHO algorithm to predict osteoporotic fractures: the first analysis of its discriminative and predictive ability in the Spanish FRIDEX cohort.

Azagra R, Roca G, Encabo G, Aguyé A, Zwart M, Güell S, Puchol N, Gene E, Casado E, Sancho P, Solà S, Torán P, Iglesias M, Gisbert MC, López-Expósito F, Pujol-Salud J, Fernandez-Hermida Y, Puente A, Rosàs M, Bou V, Antón JJ, Lansdberg G, Martín-Sánchez JC, Díez-Pérez A, Prieto-Alhambra D.

BMC Musculoskelet Disord. 2012 Oct 22;13:204. doi: 10.1186/1471-2474-13-204.

7.

Fracture risk prediction using FRAX®: a 10-year follow-up survey of the Japanese Population-Based Osteoporosis (JPOS) Cohort Study.

Tamaki J, Iki M, Kadowaki E, Sato Y, Kajita E, Kagamimori S, Kagawa Y, Yoneshima H.

Osteoporos Int. 2011 Dec;22(12):3037-45. doi: 10.1007/s00198-011-1537-x. Epub 2011 Jan 29.

PMID:
21279504
8.

Assessment and management of fracture risk in patients with Parkinson's disease.

Lyell V, Henderson E, Devine M, Gregson C.

Age Ageing. 2015 Jan;44(1):34-41. doi: 10.1093/ageing/afu122. Epub 2014 Sep 18.

PMID:
25236847
9.

Discriminative value of FRAX for fracture prediction in a cohort of Chinese postmenopausal women.

Cheung EY, Bow CH, Cheung CL, Soong C, Yeung S, Loong C, Kung A.

Osteoporos Int. 2012 Mar;23(3):871-8. doi: 10.1007/s00198-011-1647-5. Epub 2011 May 12.

PMID:
21562875
10.

Selection of women aged 50-64 yr for bone density measurement.

Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA; Manitoba Bone Density Program.

J Clin Densitom. 2013 Oct-Dec;16(4):570-8. doi: 10.1016/j.jocd.2013.01.004. Epub 2013 Feb 26.

PMID:
23452870
11.

Validation of the FRAX predictive model for major osteoporotic fracture in a historical cohort of Spanish women.

Tebé Cordomí C, Del Río LM, Di Gregorio S, Casas L, Estrada MD, Kotzeva A, Espallargues M.

J Clin Densitom. 2013 Apr-Jun;16(2):231-7. doi: 10.1016/j.jocd.2012.05.007. Epub 2012 Jun 29.

PMID:
22748778
12.

Independent clinical validation of a Canadian FRAX tool: fracture prediction and model calibration.

Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA; Manitoba Bone Density Program.

J Bone Miner Res. 2010 Nov;25(11):2350-8. doi: 10.1002/jbmr.123.

PMID:
20499367
13.

FRAX provides robust fracture prediction regardless of socioeconomic status.

Brennan SL, Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA.

Osteoporos Int. 2014 Jan;25(1):61-9. doi: 10.1007/s00198-013-2525-0. Epub 2013 Nov 5.

PMID:
24190425
14.

Assessing fracture risk in patients with osteoporosis.

McCloskey E.

Practitioner. 2013 Oct;257(1765):19-21, 2-3.

PMID:
24367877
15.

FRAX underestimates fracture risk in patients with diabetes.

Giangregorio LM, Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA.

J Bone Miner Res. 2012 Feb;27(2):301-8. doi: 10.1002/jbmr.556.

PMID:
22052532
16.

Development and application of FRAX in the management of osteoporosis in Ireland.

McGowan B, Kanis JA, Johansson H, Silke C, Whelan B.

Arch Osteoporos. 2013;8(1-2):146. doi: 10.1007/s11657-013-0146-z. Epub 2013 Aug 28.

PMID:
23982943
17.

The clinical utility of FRAX to discriminate fracture status in men and women with chronic kidney disease.

Jamal SA, West SL, Nickolas TL.

Osteoporos Int. 2014 Jan;25(1):71-6. doi: 10.1007/s00198-013-2524-1. Epub 2013 Oct 11.

PMID:
24114399
18.

Risk of fracture in patients with Parkinson's disease.

Pouwels S, Bazelier MT, de Boer A, Weber WE, Neef C, Cooper C, de Vries F.

Osteoporos Int. 2013 Aug;24(8):2283-90. doi: 10.1007/s00198-013-2300-2. Epub 2013 Feb 22.

PMID:
23430103
19.

Comparison of different screening tools (FRAX®, OST, ORAI, OSIRIS, SCORE and age alone) to identify women with increased risk of fracture. A population-based prospective study.

Rubin KH, Abrahamsen B, Friis-Holmberg T, Hjelmborg JV, Bech M, Hermann AP, Barkmann R, Glüer CC, Brixen K.

Bone. 2013 Sep;56(1):16-22. doi: 10.1016/j.bone.2013.05.002. Epub 2013 May 10.

20.

High fracture probability with FRAX usually indicates densitometric osteoporosis: implications for clinical practice.

Leslie WD, Majumdar SR, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA; Manitoba Bone Density Program.

Osteoporos Int. 2012 Jan;23(1):391-7. doi: 10.1007/s00198-011-1592-3. Epub 2011 Mar 2.

PMID:
21365460
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk